1. Avantor's CEO will present at TD Cowen's conference on March 5. 2. The presentation aims to showcase Avantor's critical role in life sciences. 3. The company serves over 300,000 customer locations globally. 4. Innovations in medical and technological sectors are highlighted in the presentation.
Company presentation may attract investment and boost trader confidence, similar to past events.
The conference attendance signifies Avantor's proactive approach, likely impacting investor perception significantly.
Immediate interest from investors could lead to price fluctuations shortly after the conference.
/PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced that President and CEO, Michael Stubblefield, will present at TD Cowen's 45th Annual Health Care Conference on Wednesday, March 5, at 11:50 a.m. Eastern Standard Time.
To hear a live audio webcast of the session, visit Events & Presentations in the Investor section of Avantor's website, ir.avantorsciences.com. A replay of the webcast will be available for 30 days.
Avantor® is a leading life science tools company and global provider of mission-critical products and services to the life sciences and advanced technology industries. We work side-by-side with customers at every step of the scientific journey to enable breakthroughs in medicine, healthcare, and technology. Our portfolio is used in virtually every stage of the most important research, development and production activities at more than 300,000 customer locations in 180 countries. For more information, visit avantorsciences.com and find us on LinkedIn, X (Twitter) and Facebook.
Allison Hosak
Senior Vice President, Global Communications
Avantor
908.329.7281
email@example.com
Eric Van Zanten
Head of External Communications
Avantor
610-529-6219
email@example.com